Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: Exp Eye Res. 2010 Jun 26;91(3):415–424. doi: 10.1016/j.exer.2010.06.018

Table 4.

Mean RGC layer loss and axon loss (bead injected compared to control) for each strain at 6 or 12 weeks.

Axon loss, 6 weeks Axon loss, 12 weeks RGC layer loss, 6 weeks RGC layer loss, 12 weeks
Strain N mean ± SD median N mean ± SD median N mean ± SD median N mean ± SD median
CD1 10 12.9 ± 11.8% 12.0% 10 32.0 ± 28.3% 25.2% 10 9.9 ± 9.5% 10.4% 10 20.1 ± 15.7% 15.1%
C57BL/6 younger 14 15.9 ± 23.5% 9.3% 10 6.5 ± 8.9%* 6.5% 14 9.3 ± 6.5% 9.0% 10 5.2 ± 12.1% 6.9%
DBA/2J 11 7.1 ± 7.6% 7.3% 13 13.9 ± 27.8% 4.8% 12 9.1 ± 7.4% 9.1% 12 4.1 ± 16.5% 1.6%
C57BL/6 older 12 10.5 ± 19.6% 5.4% 12 0.1 ± 8.2% −0.3% 12 0.0 ± 6.7% −0.3% 12 4.1 ± 7.3% 2.4%

Sample number (N), standard deviation (SD).

*

p < 0.05,

p < 0.01 for difference between injected and fellow eye, t test.